Introduction to In Vivo Survival Assessment Introduction to In Vivo Survival Assessment
B cell-based immunotherapy has shown great potential in cancer treatment applications. B cells in the mature tertiary lymphoid structures (TLS) could not only secrete antibodies but also mediate tumor apoptosis, phagocytosis, and antibody-dependent cellular cytotoxicity (as shown in Fig.1), which results in improving patient overall survival. To help...
Join our community to interact with posts!